Can we improve the treatment of congestion in heart failure?

Author： Metra Marco   Bugatti Silvia   Bettari Luca   Carubelli Valentina   Danesi Rossella   Lazzarini Valentina   Lombardi Carlo   Cas Livio Dei  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.12, Iss.9, 2011-06, pp. : 1369-1379

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A multidisciplinary cardiac rehabilitation programme can improve symptoms, functional performance and QOL among elderly patients with heart failure

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 478, 2005-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Are we ready for pharmacogenomics in heart failure?

By Charron P.   Komajda M.  

European Journal of Pharmacology, Vol. 417, Iss. 1, 2001-04 ,pp. : 1-9

Elsevier

Access to resources Recommend Favorite

Valsartan for the treatment of heart failure

By Latini Roberto   Masson Serge   Staszewsky Lidia   Maggioni Aldo P  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 1, 2004-01 ,pp. : 181-193

Informa Healthcare

Access to resources Recommend Favorite

Treatment of diastolic heart failure

By  

Inpharma, Vol. 1, Iss. 1415, 2003-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Nebivolol for the treatment of heart failure

By Riva Nicoletta   Lip Gregory YH  

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 12, 2011-12 ,pp. : 1733-1746

Informa Healthcare

Access to resources Recommend Favorite